熱門資訊> 正文
Integra LifeSciences任命Stuart Essig为首席执行官
2026-05-05 18:07
- Integra LifeSciences (IART) said Tuesday that Stuart Essig, chairman of Integra’s board of directors, has been appointed president and chief executive officer, effective May 1, 2026.
- Essig brings more than 30 years of experience in the medical technology and healthcare industries and will continue to serve as chairman.
- He succeeds Mojdeh Poul, who is pursuing other opportunities.
More on Integra LifeSciences Holdings Corporation
- Integra LifeSciences Holdings Corporation (IART) Q4 2025 Earnings Call Transcript
- Integra LifeSciences Holdings Corporation 2025 Q4 - Results - Earnings Call Presentation
- Integra LifeSciences Holdings Corporation Q1 2026 Earnings Preview
- Integra outlines $1.66B-$1.7B 2026 revenue target as new operating model drives transformation
- Seeking Alpha’s Quant Rating on Integra LifeSciences Holdings Corporation
推薦文章
一周財經日曆 | 壓軸登場！小米、拼多多等重磅財報來襲；深演智能、雲英谷科技等新股下周上市；港美股下周一休市一日
港股周報 | 利好共振！芯片股集體狂飆，兆易創新周漲超43%；阿里致股東信：將AI+雲打造成新增長動力；聯想飆漲20%刷歷史新高
美股機會日報 | 今晚11點！特朗普將親自「加冕」美聯儲新主席沃什；英偉達Vera Rubin機架售價狂飆！產業鏈所有組件迎漲價熱潮
SpaceX在發現多項問題后推迟「星艦」第12次試飛
華盛早報 | 沃什今晚11點宣誓就職美聯儲主席！雷軍稱未來兩年內存或持續漲價；Q1恆指季檢結果今晚公佈
特朗普再威脅伊朗交出濃縮鈾！稱到手后或銷燬
美股機會日報 | 伊朗稱高濃縮鈾不得運往國外；特朗普再出手！美國政府20億美元佈局量子計算；SpaceX正式遞表衝刺納斯達克
一圖看懂 | 連續兩季盈利！蔚來Q1經營利潤0.66億元，交付量超8萬輛；毛利率創近四年新高
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
